Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012, Article ID 498489, 5 pages
http://dx.doi.org/10.1100/2012/498489
Research Article

The Effects of the Melatonin Treatment on the Oxidative Stress and Apoptosis in Diabetic Eye and Brain

1Department of Pharmacology, Faculty of Medicine, Celal Bayar University, 45030 Manisa, Turkey
2Department of Physiology, Faculty of Medicine, Celal Bayar University, 45030 Manisa, Turkey
3Department of Physiology, Faculty of Medicine, Dokuz Eylul University, 35340 Izmir, Turkey
4Department of Histology and Embriology, Faculty of Medicine, Celal Bayar University, 45030 Manisa, Turkey
5Department of Vocational School of Health Services, Celal Bayar University, 45030 Manisa, Turkey
6Department of Histology, Faculty of Medicine, Celal Bayar University, 45030 Manisa, Turkey

Received 12 October 2011; Accepted 8 December 2011

Academic Editor: Eloisa Gitto

Copyright © 2012 Tuğba Gürpınar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. S. Fox, S. Coady, P. D. Sorlie et al., “Trends in cardiovascular complications of diabetes,” JAMA, vol. 292, no. 20, pp. 2495–2499, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Bonnefont-Rousselot, J. P. Bastard, M. C. Jaudon, and J. Delattre, “Consequences of the diabetic status on the oxidant/antioxidant balance,” Diabetes and Metabolism, vol. 26, no. 3, pp. 163–176, 2000. View at Google Scholar · View at Scopus
  3. G. S. Dave and K. Kalia, “Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy,” Cellular and Molecular Biology, vol. 53, no. 5, pp. 68–78, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. Schmeichel, J. D. Schmelzer, and P. A. Low, “Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy,” Diabetes, vol. 52, no. 1, pp. 165–171, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Cai and D. G. Harrison, “Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress,” Circulation Research, vol. 87, no. 10, pp. 840–844, 2000. View at Google Scholar · View at Scopus
  6. D. Pitocco, F. Zaccardi, E. Di Stasio et al., “Oxidative stress, nitric oxide, and diabetes,” Review of Diabetic Studies, vol. 7, no. 1, pp. 15–25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. G. Ferrini, G. Nolazco, D. Vernet, N. F. Gonzalez-Cadavid, and J. Berman, “Increased vaginal oxidative stress, apoptosis, and inducible nitric oxide synthase in a diabetic rat model: implications for vaginal fibrosis,” Fertility and Sterility, vol. 86, no. 4, pp. 1152–1163, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. M. McCann, C. Mastronardi, A. De Laurentiis, and V. Rettori, “The nitric oxide theory of aging revisited,” Annals of the New York Academy of Sciences, vol. 1057, pp. 64–84, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Nishida, “Metabolic effects of melatonin on oxidative stress and diabetes mellitus,” Endocrine, vol. 27, no. 2, pp. 131–135, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. F. J. Padillo, A. Cruz, C. Navarrete et al., “Melatonin prevents oxidative stress and hepatocyte cell death induced by experimental cholestasis,” Free Radical Research, vol. 38, no. 7, pp. 697–704, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. Pei, S. F. Pang, and R. T. F. Cheung, “Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model,” Stroke, vol. 34, no. 3, pp. 770–775, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Kilic, U. Kilic, R. J. Reiter, C. L. Bassetti, and D. M. Hermann, “Prophylactic use of melatonin protects against focal cerebral ischemia in mice: role of endothelin converting enzyme-1,” Journal of Pineal Research, vol. 37, no. 4, pp. 247–251, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. R. J. Reiter, D. X. Tan, C. Osuna, and E. Gitto, “Actions of melatonin in the reduction of oxidative stress: a review,” Journal of Biomedical Science, vol. 7, no. 6, pp. 444–458, 2000. View at Google Scholar · View at Scopus
  14. I. Bettahi, J. M. Guerrero, R. J. Reiter, and C. Osuna, “Physiological concentrations of melatonin inhibit the norepinephrine-induced activation of prostaglandin E2 and cyclic AMP production in rat hypothalamus: a mechanism involving inhibition of nitric oxide synthase,” Journal of Pineal Research, vol. 25, no. 1, pp. 34–40, 1998. View at Google Scholar · View at Scopus
  15. V. S. N. Rao, F. A. Santos, R. M. Silva, and M. G. Teixiera, “Effects of nitric oxide synthase inhibitors and melatonin on the hyperglycemic response to streptozotocin in rats,” Vascular Pharmacology, vol. 38, no. 3, pp. 127–130, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. D. A. Sáenz, A. G. Turjanski, G. B. Sacca et al., “Physiological concentrations of melatonin inhibit the nitridergic pathway in the Syrian hamster retina,” Journal of Pineal Research, vol. 33, no. 1, pp. 31–36, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. W. G. Mayhan and F. M. Faraci, “Responses of cerebral arterioles in diabetic rats to activation of ATP- sensitive potassium channels,” American Journal of Physiology, vol. 265, no. 1, pp. H152–H157, 1993. View at Google Scholar · View at Scopus
  18. N. Aksoy, H. Vural, T. Sabuncu, and S. Aksoy, “Effects of melatonin on oxidative-antioxidative status of tissues in streptozotocin-induced diabetic rats,” Cell Biochemistry and Function, vol. 21, no. 2, pp. 121–125, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Golbidi, S. A. Ebadi, and I. Laher, “Antioxidants in the treatment of diabetes,” Current Diabetes Reviews, vol. 7, no. 2, pp. 106–125, 2011. View at Publisher · View at Google Scholar
  20. E. K. Tamura, C. L. M. Silva, and R. P. Markus, “Melatonin inhibits endothelial nitric oxide production in vitro,” Journal of Pineal Research, vol. 41, no. 3, pp. 267–274, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Jaworek, T. Brzozowski, and S. J. Konturek, “Melatonin as an organoprotector in the stomach and the pancreas,” Journal of Pineal Research, vol. 38, no. 2, pp. 73–83, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. F. C. Muñoz-Casares, F. J. Padillo, J. Briceño et al., “Melatonin reduces apoptosis and necrosis induced by ischemia/reperfusion injury of the pancreas,” Journal of Pineal Research, vol. 40, no. 3, pp. 195–203, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Piotrowski, K. Wierzbicka, and M. Smiałek, “Neuronal death in the rat hippocampus in experimental diabetes and cerebral ischaemia treated with antioxidants,” Folia Neuropathologica, vol. 39, no. 3, pp. 147–154, 2001. View at Google Scholar · View at Scopus
  24. T. Gürpınar, N. Ekerbiçer, N. U. Harzadin, T. Barut, F. Tarakçi, and M. I. Tuglu, “Statin treatment reduces oxidative stress-associated apoptosis of sciatic nerve in diabetes mellitus,” Biotechnic and Histochemistry, vol. 86, no. 6, pp. 373–378, 2011. View at Publisher · View at Google Scholar